BioPharma
29 July, 2026 | Wednesday | News
HoneyNaps Expands Global CRO Services with AI-Powered Sleep Analytics Platform
Strengthens specialized AI-powered sleep data analysis services for global pharmaceutical, medical device, and healthcare companies Targets the rapidly growing global sleep clinical research market with adva...
Lab
29 July, 2026 | Wednesday | News
Waters Launches Next-Generation IVD Mass Spectrometer for High-Sensitivity Clinical Diagnostics
Brings Xevo™ TQ Absolute XR Mass Spectrometer's industry-leading tandem quadrupole MS sensitivity to clinical applications across women's health, cancer assessment, and toxicology. Offers 5x greater se...
BioTech
29 July, 2026 | Wednesday | News
Jyong Biotech Expands Global Licensing Push for Botanical Therapy Targeting Enlarging BPH Market
Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics, tod...
Contract Services
24 July, 2026 | Friday | News
Samsung Bioepis Secures Exclusive Commercial Rights to Nectin-4 ADC Candidate SBE303
Ÿ Under the agreement, Samsung Bioepis will obtain exclusive commercial licensing rights to SBE303, an ADC candidate currently in joint development Ÿ This agreement ...
Consumer Health
28 July, 2026 | Tuesday | News
Roche Secures US FDA Clearance for PCR Test Detecting Bacterial Vaginosis and Candida Vaginitis
The new PCR test uses clinician-collected or clinician-instructed, self-collected vaginal swab specimens to simultaneously detect organisms associated with Bacterial vaginosis (BV) and Candida ...
Medtech
28 July, 2026 | Tuesday | News
Advita Introduces Activit-E Vitamin E Polyethylene to Equinoxe Reverse Shoulder System
Advita Ortho, a global medical technology leader, announced the first clinical use of humeral liners manufactured with Activit-E® polyethylene, bringing its advanced vitamin E polyethylene technology ...
Cell & Gene
24 July, 2026 | Friday | News
Tikva Allocell Raises $8M Series A to Advance Off-the-Shelf CAR-T Therapy for Solid Tumours
Funding will support completion of IND-enabling activities and planned year-end IND submission for TAVST01, Tikva's lead off-the-shelf CAR-T candidate targeting B7-H3-positive solid tumors Tikva Allocell Pte. ...
White Paper
29 July, 2026 | Wednesday | News
APAC Physicians Back Pulsed Field Ablation, But Referral Gaps Delay AFib Treatment
Product Spot Light
29 July, 2026 | Wednesday | News
Waters Launches Next-Generation IVD Mass Spectrometer for High-Sensitivity Clinical Diagnostics
Premium Article
29 July, 2026 | Wednesday | Analysis
8 APAC Assets That Went Global The Out-Licensing Class of 2025 to 2026
Bio Invest
24 July, 2026 | Friday | News
Tikva Allocell Raises $8M Series A to Advance Off-the-Shelf CAR-T Therapy for Solid Tumours
Biopharma APAC Infomercial
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
